Serzone Side Effects May Lead To Liver Failure Lawsuits
Serzone | Lawsuits, Lawyers | Side Effects: Liver Failure, Death, Liver Transplant, Liver Damage
Serzone Has Been Removed From the U.S. Market
On May 19, 2004 Bristol Myers Squibb announced it would stop selling Serzone in the United States. The drug had previously been removed from all countries except the U.S.
On January 8th, 2003, Serzone was removed from the market in all European countries because it has been linked to 26 deaths from liver damage. This follows a black box warning issued by the FDA in 2001.
In December, 2001 The Food and Drug Administration notified Bristol-Myers Squibb Co. that it must include a so-called black-box warning on its label for the antidepressant Serzone advising patients that rare but possibly life-threatening liver failure can occur with use of the drug. A black-box warning label is the most serious warning issued by the Federal Food and Drug Administration.
The black-box designation refers to a black outline surrounding a section of the label and of the Physicians' Desk Reference, reserved for only the most serious side effects. The agency sent a notice this week to the New York-based company and soon will require Bristol-Myers to warn doctors by letter that patients could suffer severe liver failure that could lead to death or necessitate a liver transplant.
Serzone is an antidepressant manufactured by Bristol-Myers Squibb; the generic name for Serzone is nefazodone hydrochloride. Serzone was approved by the FDA for use in the United States for the treatment of depression in 1994. Serzone is an anti-depressant in a class of its own in terms of its structure and composition, Serzone shares some characteristics with other serotonin uptake inhibitors like Prozac, Paxil and Zoloft.
Legal Help For Victims Affected By Serzone
If you or a loved one took Serzone and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).